Yaron Werber
Stock Analyst at TD Cowen
(4.95)
# 143
Out of 5,119 analysts
784
Total ratings
56.7%
Success rate
25.1%
Average return
Main Sectors:
Stocks Rated by Yaron Werber
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONC BeOne Medicines AG | Reiterated: Buy | $454 → $477 | $406.96 | +17.21% | 46 | Nov 6, 2026 | |
| AMGN Amgen | Reiterated: Buy | $452 → $531 | $460.42 | +15.33% | 77 | Nov 4, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $18 → $19 | $15.43 | +23.14% | 47 | Nov 4, 2026 | |
| EXEL Exelixis | Reiterated: Buy | $55 → $76 | $69.57 | +9.24% | 36 | Oct 30, 2026 | |
| GMAB Genmab | Rated: Buy | $43 → $52 | $53.63 | -3.04% | 28 | Oct 26, 2026 | |
| ROIV Roivant Sciences | Reiterated: Buy | $55 → $62 | $38.88 | +59.47% | 28 | Oct 21, 2026 | |
| STOK Stoke Therapeutics | Reiterated: Buy | $60 | $26.54 | +126.07% | 22 | Oct 13, 2026 | |
| ALEC Alector | Reiterated: Hold | n/a | $2.29 | - | 26 | Oct 5, 2026 | |
| FHTX Foghorn Therapeutics | Downgraded: Hold | n/a | $1.87 | - | 16 | Oct 1, 2026 | |
| KLRA Kailera Therapeutics | Reiterated: Buy | $57 | $12.97 | +339.48% | 6 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $34 | $29.63 | +14.75% | 6 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $84 | $39.42 | +113.09% | 47 | Sep 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,146 → $1,353 | $927.21 | +45.92% | 56 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $325 → $341 | $256.82 | +32.78% | 28 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $29 → $24 | $23.40 | +2.56% | 20 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $48.85 | - | 8 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $18.60 | - | 19 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $150 | $86.03 | +74.36% | 12 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.16 | - | 19 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $227 | $276.22 | -17.92% | 1 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.86 | - | 14 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $3.23 | - | 11 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.88 | - | 3 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.26 | - | 12 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $29.87 | - | 14 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $94 | $87.51 | +7.42% | 28 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.98 | - | 6 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | - | 12 | Mar 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.73 | - | 11 | Mar 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $230 | $313.84 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.68 | n/a | 4 | Mar 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $50.90 | n/a | 1 | Mar 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $25 → $3 | $3.73 | n/a | 6 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $6.83 | n/a | 2 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $684 → $565 | $904.35 | n/a | 30 | Feb 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $7.33 | n/a | 1 | Dec 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.39 | n/a | 10 | Aug 5, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.39 | n/a | 6 | Feb 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.37 | n/a | 6 | Dec 31, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $31.65 | n/a | 4 | Aug 12, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $497 → $345 | $248.35 | n/a | 16 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $120 → $110 | $166.89 | n/a | 13 | Feb 25, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $266 → $94 | $8.25 | n/a | 5 | Sep 3, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $137 → $132 | $29.41 | n/a | 2 | Feb 18, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $37 | $7.87 | n/a | 1 | Nov 10, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | n/a | $17.82 | n/a | 3 | Apr 22, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $7 → $5 | $39.65 | n/a | 5 | Jun 4, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $63 → $100 | $547.09 | n/a | 7 | Apr 19, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $0.0001 | n/a | 1 | Mar 12, 2012 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $50.33 | n/a | 1 | Nov 17, 2010 |
BeOne Medicines AG
Nov 6, 2026
Reiterated: Buy
Price Target: $454 → $477
Current: $406.96
Upside: +17.21%
Amgen
Nov 4, 2026
Reiterated: Buy
Price Target: $452 → $531
Current: $460.42
Upside: +15.33%
Ultragenyx Pharmaceutical
Nov 4, 2026
Reiterated: Buy
Price Target: $18 → $19
Current: $15.43
Upside: +23.14%
Exelixis
Oct 30, 2026
Reiterated: Buy
Price Target: $55 → $76
Current: $69.57
Upside: +9.24%
Genmab
Oct 26, 2026
Rated: Buy
Price Target: $43 → $52
Current: $53.63
Upside: -3.04%
Roivant Sciences
Oct 21, 2026
Reiterated: Buy
Price Target: $55 → $62
Current: $38.88
Upside: +59.47%
Stoke Therapeutics
Oct 13, 2026
Reiterated: Buy
Price Target: $60
Current: $26.54
Upside: +126.07%
Alector
Oct 5, 2026
Reiterated: Hold
Price Target: n/a
Current: $2.29
Upside: -
Foghorn Therapeutics
Oct 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.87
Upside: -
Kailera Therapeutics
Sep 29, 2026
Reiterated: Buy
Price Target: $57
Current: $12.97
Upside: +339.48%
Sep 29, 2026
Initiated Coverage: Buy
Price Target: $34
Current: $29.63
Upside: +14.75%
Sep 23, 2026
Reiterated: Buy
Price Target: $84
Current: $39.42
Upside: +113.09%
Aug 17, 2026
Reiterated: Buy
Price Target: $1,146 → $1,353
Current: $927.21
Upside: +45.92%
Aug 13, 2026
Reiterated: Buy
Price Target: $325 → $341
Current: $256.82
Upside: +32.78%
Aug 12, 2026
Rated: Hold
Price Target: $29 → $24
Current: $23.40
Upside: +2.56%
Aug 11, 2026
Reiterated: Buy
Price Target: n/a
Current: $48.85
Upside: -
Aug 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $18.60
Upside: -
Aug 5, 2026
Rated: Buy
Price Target: $150
Current: $86.03
Upside: +74.36%
Jun 1, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.16
Upside: -
May 18, 2026
Reiterated: Buy
Price Target: $227
Current: $276.22
Upside: -17.92%
May 15, 2026
Downgraded: Hold
Price Target: n/a
Current: $16.86
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $3.23
Upside: -
May 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.88
Upside: -
May 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.26
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: n/a
Current: $29.87
Upside: -
May 5, 2026
Reiterated: Hold
Price Target: $94
Current: $87.51
Upside: +7.42%
Apr 21, 2026
Downgraded: Hold
Price Target: n/a
Current: $3.98
Upside: -
Mar 31, 2026
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: -
Mar 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.73
Upside: -
May 21, 2025
Reiterated: Buy
Price Target: $230
Current: $313.84
Upside: n/a
Mar 14, 2024
Downgraded: Hold
Price Target: n/a
Current: $3.68
Upside: n/a
Mar 11, 2024
Reiterated: Buy
Price Target: n/a
Current: $50.90
Upside: n/a
Jun 26, 2023
Reiterated: Hold
Price Target: $25 → $3
Current: $3.73
Upside: n/a
Nov 1, 2022
Downgraded: Hold
Price Target: n/a
Current: $6.83
Upside: n/a
Feb 8, 2021
Reiterated: Hold
Price Target: $684 → $565
Current: $904.35
Upside: n/a
Dec 14, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $7.33
Upside: n/a
Aug 5, 2020
Reiterated: Buy
Price Target: n/a
Current: $2.39
Upside: n/a
Feb 21, 2020
Rated: Hold
Price Target: n/a
Current: $2.39
Upside: n/a
Dec 31, 2019
Reiterated: Hold
Price Target: n/a
Current: $3.37
Upside: n/a
Aug 12, 2019
Reiterated: Hold
Price Target: n/a
Current: $31.65
Upside: n/a
Feb 25, 2016
Rated: Buy
Price Target: $497 → $345
Current: $248.35
Upside: n/a
Feb 25, 2016
Initiated Coverage: Buy
Price Target: $120 → $110
Current: $166.89
Upside: n/a
Sep 3, 2015
Initiated Coverage: Buy
Price Target: $266 → $94
Current: $8.25
Upside: n/a
Feb 18, 2015
Reiterated: Hold
Price Target: $137 → $132
Current: $29.41
Upside: n/a
Nov 10, 2014
Initiated Coverage: Buy
Price Target: $37
Current: $7.87
Upside: n/a
Apr 22, 2014
Upgraded: Hold
Price Target: n/a
Current: $17.82
Upside: n/a
Jun 4, 2013
Reiterated: Hold
Price Target: $7 → $5
Current: $39.65
Upside: n/a
Apr 19, 2013
Reiterated: Buy
Price Target: $63 → $100
Current: $547.09
Upside: n/a
Mar 12, 2012
Downgraded: Hold
Price Target: $3
Current: $0.0001
Upside: n/a
Nov 17, 2010
Downgraded: Hold
Price Target: n/a
Current: $50.33
Upside: n/a